Drainage Alone or Combined with Anti-tumor Therapy for Treatment of Obstructive Jaundice Caused by Recurrence and Metastasis after Primary Tumor Resection

Abstract

Aim: To compare drainage alone or combined with anti-tumor therapy for treatment of obstructive jaundice caused by recurrence and metastasis after primary tumor resection. Materials and Methods: We collect 42 patients with obstructive jaundice caused by recurrence and metastasis after tumor resection from January 2008 -August 2012, for which percutaneous transhepatic catheter drainage (pTCD)/ percutaneous transhepatic biliary stenting (pTBS) were performed. In 25 patients drainage was combined with anti-tumor treatment, antineoplastic therapy including intra/postprodure local treatment and postoperative systemic chemotherapy, the other 17 undergoing drainage only. We assessed the two kinds of treatment with regard to patient prognosis. Results: Both treatments demonstrated good effects in reducing bilirubin levels in the short term and promoting liver function. The time to reobstruction was 125 days in the combined group and 89 days in the drainage only group; the mean survival times were 185 and 128 days, the differences being significant. Conclusions: Interventional drainage in the treatment of the obstructive jaundice caused by recurrence and metastasis after tumor resection can decrease bilirubin level quickly in a short term and promote the liver function recovery. Combined treatment prolongs the survival time and period before reobstruction as compared to drainage only.

Percutaneous Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction Caused by Recurrence and Metastasis after Primary Tumor Resection

“…Due to the many lymph nodes around the hepatic hilum, a metastatic tumor can easily cause hilar lymph node enlargement, which could compress the bile duct and cause obstructive jaundice [7]. Liver metastasis and remnant liver recurrence after resection around the hepatic hilar bile duct can also invade or compress the hilar bile duct and cause obstructive jaundice.…”

“…Most of these patients lost the chance of a second operation when recurrence of the primary tumor was transferred to the liver and the lymph nodes around the hilum or the bile duct [7]. Patients with biliary obstruction who had a history of primary tumor resection have limited life expectancy because of the limited stent patency and tumor progression.…”

Screening for Patients with Non-small Cell Lung Cancer Who Could Survive Long Term Chemotherapy

“…Analysis was performed using Statistica version 8.0 software (StatSoft Inc., Tulsa, OK) with p<0.05 described as statistically significant. We have enough experience in conducting medical researches, and have published some results elsewhere (Qian et al, 2014;Ji et al, 2014;Huang et al, 2014;Wu et al, 2014;Xiao et al, 2014;Lu et al, 2014;Xu et al, 2014;Gong et al, 2014;Wu et al, 2013;. …”

A Predictive Model for Evaluating Responsiveness to Pemetrexed Treatment in Patients with Advanced Colorectal Cancer

“…Stata version 8.0 (StatSoft Inc., Tulsa, OK) was used to analyze data. We have enough experience in conducting medical researches, and have published some results elsewhere Wei et al, 2013;Wu et al, 2013;Gong et al, 2014;Lu et al, 2014;Xiao et al, 2014;Xu et al, 2014).…”